RNA, 7SL, cytoplasmic 28, pseudogene (RN7SL28P)

RNA, 7SL, cytoplasmic 28, pseudogene (RN7SL28P) is classified as a **pseudogene** of the 7SL RNA gene family. Pseudogenes are DNA sequences similar to known genes but generally nonfunctional due to mutations, truncations, or lack of regulatory elements required for gene expression[4][8]. RN7SL28P is not believed to transcribe a functional RNA or protein product and shows a truncated or rearranged sequence compared to the functional 7SL RNA gene[4][8]. Its sequence suggests it originated from a retrotransposition or partial duplication event in the genome[4]. Like other 7SL RNA pseudogenes, it is homologous to the 7SL RNA, which is an essential component of the **signal recognition particle (SRP)** involved in targeting secretory and membrane proteins to the endoplasmic reticulum[6]. However, evidence suggests RN7SL28P and most related pseudogenes do not contribute to functional SRP activity and are not therapeutic or drug targets. Because it is a pseudogene with no proven regulatory or coding function, **RN7SL28P should not be considered a classical molecular target along the lines of receptors, enzymes, or druggable RNAs**[1][4][8]. There are no known disease associations, drug interactions, or biomarker uses for this pseudogene specifically. Some 7SL RNA pseudogenes in general may be transcribed at low levels or play minor regulatory roles, but there is no evidence that RN7SL28P itself does so[4][8]. The gene symbol and description are accurate; however, if your intention was to identify a therapeutic or pharmacological target, **RN7SL28P is not suitable** due to its classification as a nonfunctional pseudogene rather than an active biological molecule[1][4][8].

Other names

RN7SL28P7SL RNA pseudogene 28RNA, 7SL, cytoplasmic 28, pseudogene

Not applicable (not a functional protein or established RNA target)